INOVIO PHARMACEUTICALS, INC. Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities
INOVIO PHARMACEUTICALS, INC. (INO) reported Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities of $0 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther · last filed 2020-11-09
- INOVIO PHARMACEUTICALS, INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2020-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2019-09-30 was -$2.18M.
- INOVIO PHARMACEUTICALS, INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2018-09-30 was $0.00.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 3 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 9 month |
|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 |
| 2019-09-30 | -$2.18M 10-Q · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |